Filing Details

Accession Number:
0001127602-24-009474
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-11 18:41:27
Reporting Period:
2024-03-07
Accepted Time:
2024-03-11 18:41:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
859737 Hologic Inc HOLX X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) 042902449
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1199735 Sally Crawford 250 Campus Drive
Marlborough MA 01752
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-03-07 1,572 $0.00 132,927 No 4 A Direct
Common Stock Acquisiton 2024-03-08 9,039 $26.74 141,966 No 4 M Direct
Common Stock Disposition 2024-03-08 9,039 $76.40 132,927 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Acquisiton 2024-03-07 4,536 $0.00 4,536 $76.32
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2024-03-08 9,039 $0.00 9,039 $26.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,536 2034-03-07 No 4 A Direct
0 2016-01-01 2025-01-01 No 4 M Direct
Footnotes
  1. Represents restricted stock units which vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock.
  2. Restricted stock units are settled in shares of common stock on a one-for-one basis.
  3. The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $76.40 to $76.43 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
  4. Options become exercisable on the date of the 2025 Annual Meeting of Stockholders.